Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « H. Kameda »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
H. K Llberg < H. Kameda < H. Kanda  Facettes :

List of bibliographic references indexed by H. Kameda

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
002B93 (2013) T. Kondo [Japon] ; K. Yoshimoto [Japon] ; K. Suzuki [Japon] ; H. Kameda [Japon] ; K. Amano ; T. Takeuchi [Japon]SAT0078 Decreased peripheral CD3 zeta chain expression in patients with active rheumatoid arthritis can be restored by various biologic DMARDs and methotrexate
002F25 (2013) N. Nishina [Japon] ; J. Kikuchi [Japon] ; M. Hashizume [Japon] ; K. Yoshimoto [Japon] ; H. Kameda [Japon] ; T. Takeuchi [Japon]FRI0001 Baseline soluble interleukin-6 receptor levels predict the clinical effectiveness of tocilizumab in patients with rheumatoid arthritis
003071 (2013) Y. Tanaka ; T. Takeuchi [Japon] ; K. Amano ; E. Sato [Japon] ; M. Nawata ; H. Nagasawa ; D. Hoshi [Japon] ; K. Saito ; S. Fukuyo ; K. Hanami ; H. Kameda [Japon] ; T. Kurasawa ; Y. Kaneko [Japon] ; H. Yamanaka [Japon]AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study
003111 (2013) K. Izumi [Japon] ; Y. Kaneko [Japon] ; H. Yasuoka [Japon] ; N. Seta [Japon] ; H. Kameda [Japon] ; M. Kuwana [Japon] ; T. Takeuchi [Japon]AB0544 Efficacy and safety of tocilizumab in patients with rheumatoid arthritis in the presence or absence of previous treatment with biologics and concomitant treatment with methotrexate
003177 (2013) Y. Kaneko [Japon] ; M. Kuwana [Japon] ; H. Kameda [Japon] ; T. Takeuchi [Japon]AB0347 Validation of the clinical remission criteria in rheumatoid arthritis at keio immunotherapy center
003199 (2013) K. Izumi [Japon] ; Y. Kaneko [Japon] ; H. Yasuoka [Japon] ; N. Seta [Japon] ; H. Kameda [Japon] ; M. Kuwana [Japon] ; T. Takeuchi [Japon]AB0319 Treatment with tocilizumab improved rheumatoid arthritis patients clinically and structurally regardless of the prior use of anti-tnf biologics in daily clinical practice
003286 (2013) J. Kikuchi [Japon] ; M. Shiina [Japon] ; M. Hashizume [Japon] ; M. Mihara [Japon] ; K. Yoshimoto [Japon] ; H. Kameda [Japon] ; T. Takeuchi [Japon]AB0163 Factors associated with the expansion of TH17 cells in peripheral blood of ra patients: Possible different effect between anti-IL-6 and anti-TNF therapies
003296 (2013) M. Hashizume ; N. Nishina [Japon] ; J. Kikuchi [Japon] ; K. Yoshimoto [Japon] ; H. Kameda [Japon] ; T. Takeuchi [Japon]AB0054 A rapid and marked reduction of serum vegf via blocking il-6 signal was associated with early clinical responses to tocilizumab and infliximab in patients with rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "H. Kameda" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "H. Kameda" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    H. Kameda
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021